Jauss Polymers (526001)
Asset PlayScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹7.81 |
| Market Cap | ₹3.61 Cr |
| P/E Ratio | 0 |
| ROCE | -1.07% |
| ROE | -50.03% |
| Dividend Yield | 0% |
| Profit Growth | -9,040% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹6.84 — ₹37.11 |
| Sector | Industrial Products |
| Book Value | ₹19.55 |
Strengths
- Price-to-book of 0.40 offers a deep discount to stated book value of ₹19.55.
- Market capitalization of just ₹4 Cr makes this a small, lower-absolute-capital situation if assets can be realized.
- The stock has already fallen from ₹37.11 to ₹7.81, reducing speculative froth in the price.
Concerns
- Latest quarter shows zero sales of ₹0 Cr and a net loss of ₹5 Cr, leaving no operating earnings to validate the business.
- ROE is deeply negative at -50.03%, indicating rapid destruction of shareholder book value.
- Piotroski F-Score of 2/9 suggests very poor financial health.
- Profit growth of -9,040% and no dividend provide no income or growth cushion.
AI Analysis
At first glance, Jauss Polymers sells at ₹7.81 against a book value of ₹19.55, a P/B of 0.40. That looks like the classic Graham bargain. But my first rule is never to judge a business by the balance sheet alone. This is a packaging company with reported sales of ₹0 Cr in the latest quarter and a net loss of ₹5 Cr. With no revenue, there is no earnings power to value. The P/E is meaningless, and profit growth of -9,040% is a red flag, not a figure to cheer. ROE is a deeply negative -50.03%; the company is burning shareholder capital at an alarming speed. ROCE at -1.07% confirms that even the capital employed is not earning an acceptable return. The Piotroski F-score of 2 out of 9 reinforces my caution: financial health is poor. If the book value is real and liquidation value is accessible, the discount might be interesting. But book value means little if losses keep consuming it. There is no dividend, no sales growth, and I have no promoter holding data to tell me whether insiders are aligned with me. Market cap is only ₹4 Cr, so this is a microcap with very little room for error. Graham would demand a margin of safety; a low P/B provides some, but the negative earnings and zero sales remove most of it. I cannot call this a wonderful business. It may be a potential asset play, but only if the assets can be realized or the operations restarted. I would rather wait for evidence of sales coming back and losses narrowing before committing capital.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer